Stakeholder engagement (D2D Pillar 3)

Stakeholder engagement, which is one of three pillars with the Design to Delivery (D2D) hub, has an overall goal of ensuring early and ongoing strategic engagement with a wide range of influential stakeholders, including policymakers, advocates, providers, and regulators, among others, for continued, meaningful dialogue about the MATRIX paradigm for R&D, its pipeline of products and plans for early phase clinical evaluation in humans in the global north and sub-Saharan Africa.

Activities aim to seek stakeholders’ views, perspectives and suggestions regarding new products and the design and conduct of clinical trials and feed this back to product developers and researchers within the MATRIX collaborative, and in turn, communicate back to stakeholders what has/is being changed as a result.

Stakeholder engagement will be critical to identifying potential barriers, facilitators, challenges and opportunities that are product-specific or agnostic and relevant to both the African region and within each country. Through structured engagement, MATRIX aims to build sustainable partnerships by ensuring activities pursued are based on the principles of Good Participatory Practices (GPP) guidelines. 

Key contacts

Nandi Luthuli (South Africa)
Definate Nhamo (Zimbabwe)
Daisy Ouya (Kenya)
Leonard Solai (Prime Liaison)
Sinazo Pato (Prime Liaison)
Thesla Palanee-Phillips